Delivery Order SPE2DR25D3021-SPE2DR26FS8MX
- Not listed
- The Defense Logistics Agency awarded a $5,840.52 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price contract with no set-aside designation, competitively awarded through an open procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 19, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under open competition requirements. The ultimate completion date is October 6, 2025, and the product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a ceiling value of $1,460.13 and an ultimate completion date of November 24, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $5,840.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, with an ultimate completion date of December 26, 2025. This non-set-aside contract was competitively awarded on December 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under the company's larger pharmaceutical supply contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $1,460.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging) under contract number 4570186524. The order, which was competitively awarded without set-aside provisions, is scheduled for completion by December 29, 2025, with performance occurring at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's ability to compete...
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a $1,460.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-count package) on December 3, 2025, with completion targeted for December 24, 2025. This competitive award carries no set-aside designation and represents a direct delivery against AmerisourceBergen's larger federal contract vehicle. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,920.26 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on November 3, 2025, with completion scheduled for November 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- SPE2DR25D3021Indefinite Delivery Contract
- SPE2DR25D3021-SPE2DR26FS8MXDelivery Order
The Defense Logistics Agency awarded a $1,460.13 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 30, 2025. This delivery order represents a small-value transaction under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains, demonstrating its capability to fulfill diverse federal healthcare supply requirements on an ongoing basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/7/25 |